SE0100158D0 - Novel method and composition for local treatment of Meniere´s disease and tinnitus - Google Patents

Novel method and composition for local treatment of Meniere´s disease and tinnitus

Info

Publication number
SE0100158D0
SE0100158D0 SE0100158A SE0100158A SE0100158D0 SE 0100158 D0 SE0100158 D0 SE 0100158D0 SE 0100158 A SE0100158 A SE 0100158A SE 0100158 A SE0100158 A SE 0100158A SE 0100158 D0 SE0100158 D0 SE 0100158D0
Authority
SE
Sweden
Prior art keywords
meniere
tinnitus
disease
novel method
composition
Prior art date
Application number
SE0100158A
Other languages
English (en)
Inventor
Helge Rask-Andersen
Johan Stjernschantz
Original Assignee
Synphora Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synphora Ab filed Critical Synphora Ab
Priority to SE0100158A priority Critical patent/SE0100158D0/sv
Publication of SE0100158D0 publication Critical patent/SE0100158D0/sv
Priority to AU2002219765A priority patent/AU2002219765B2/en
Priority to CA2434272A priority patent/CA2434272C/en
Priority to PCT/SE2002/000062 priority patent/WO2002056890A1/en
Priority to PL02362803A priority patent/PL362803A1/xx
Priority to MXPA03006439A priority patent/MXPA03006439A/es
Priority to EP02732105A priority patent/EP1351693B1/en
Priority to US10/343,789 priority patent/US7498360B2/en
Priority to AT02732105T priority patent/ATE470446T1/de
Priority to BR0206568-1A priority patent/BR0206568A/pt
Priority to JP2002557397A priority patent/JP4202135B2/ja
Priority to CNB028039297A priority patent/CN1307998C/zh
Priority to DE60236639T priority patent/DE60236639D1/de
Priority to NZ526972A priority patent/NZ526972A/en
Priority to HK04105057A priority patent/HK1061975A1/xx
Priority to US11/029,532 priority patent/US20050171054A1/en
Priority to JP2008197576A priority patent/JP4960931B2/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SE0100158A 2001-01-19 2001-01-19 Novel method and composition for local treatment of Meniere´s disease and tinnitus SE0100158D0 (sv)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SE0100158A SE0100158D0 (sv) 2001-01-19 2001-01-19 Novel method and composition for local treatment of Meniere´s disease and tinnitus
NZ526972A NZ526972A (en) 2001-01-19 2002-01-15 Novel method and compositions for local treatment of Meniere's disease, tinnitus and/or hearing loss
EP02732105A EP1351693B1 (en) 2001-01-19 2002-01-15 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
AT02732105T ATE470446T1 (de) 2001-01-19 2002-01-15 Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust
PCT/SE2002/000062 WO2002056890A1 (en) 2001-01-19 2002-01-15 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
PL02362803A PL362803A1 (en) 2001-01-19 2002-01-15 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
MXPA03006439A MXPA03006439A (es) 2001-01-19 2002-01-15 Metodo y composiciones novedosos para tratamiento local del mal del meniere, zumbido de oidos y/o perdida de oido.
AU2002219765A AU2002219765B2 (en) 2001-01-19 2002-01-15 Novel method and compositions for local treatment of meniere's disease, tinnitus and/or hearing loss
US10/343,789 US7498360B2 (en) 2001-01-19 2002-01-15 Method and compositions for local treatment of Meniere's disease, tinnitus and/or hearing loss
CA2434272A CA2434272C (en) 2001-01-19 2002-01-15 Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss
BR0206568-1A BR0206568A (pt) 2001-01-19 2002-01-15 Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição
JP2002557397A JP4202135B2 (ja) 2001-01-19 2002-01-15 メニエール病、耳鳴および／または聴覚損失の局所処置のための新規な方法および組成物
CNB028039297A CN1307998C (zh) 2001-01-19 2002-01-15 用于局部治疗美尼埃尔氏疾病、耳鸣和/或听力损伤的新方法和组合物
DE60236639T DE60236639D1 (de) 2001-01-19 2002-01-15 Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust
HK04105057A HK1061975A1 (en) 2001-01-19 2004-07-12 Novel method and compostions for local treatment of meniere's disease, tinnitus and/or hearing loss
US11/029,532 US20050171054A1 (en) 2001-01-19 2005-01-05 Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss
JP2008197576A JP4960931B2 (ja) 2001-01-19 2008-07-31 メニエール病、耳鳴および／または聴覚損失の局所処置のための新規な方法および組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100158A SE0100158D0 (sv) 2001-01-19 2001-01-19 Novel method and composition for local treatment of Meniere´s disease and tinnitus

Publications (1)

Publication Number Publication Date
SE0100158D0 true SE0100158D0 (sv) 2001-01-19

Family

ID=20282672

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100158A SE0100158D0 (sv) 2001-01-19 2001-01-19 Novel method and composition for local treatment of Meniere´s disease and tinnitus

Country Status (15)

Country Link
US (1) US7498360B2 (sv)
EP (1) EP1351693B1 (sv)
JP (2) JP4202135B2 (sv)
CN (1) CN1307998C (sv)
AT (1) ATE470446T1 (sv)
AU (1) AU2002219765B2 (sv)
BR (1) BR0206568A (sv)
CA (1) CA2434272C (sv)
DE (1) DE60236639D1 (sv)
HK (1) HK1061975A1 (sv)
MX (1) MXPA03006439A (sv)
NZ (1) NZ526972A (sv)
PL (1) PL362803A1 (sv)
SE (1) SE0100158D0 (sv)
WO (1) WO2002056890A1 (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050171054A1 (en) * 2001-01-19 2005-08-04 Helge Rask-Andersen Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss
WO2004066975A1 (en) * 2002-12-18 2004-08-12 Hough Ear Institute Otologic nanotechnology
US7723311B2 (en) 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
US8651113B2 (en) 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
US20070249695A1 (en) * 2004-06-30 2007-10-25 Kazuya Kawata Preventive and/or Therapeutic Agents for Meniere's Disease
EP1986666A1 (en) * 2006-02-06 2008-11-05 Synphora AB Novel method and compositions for treatment of tinnitus
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
RU2499592C2 (ru) 2008-04-21 2013-11-27 Отономи, Инк. Фармацевтическая композиция для лечения ушных заболеваний
MY161021A (en) 2008-05-14 2017-03-31 Otonomy Inc Controlled release corticosteroid and methods for the treatment of otic disorders
US8648119B2 (en) 2008-05-23 2014-02-11 Otonomy, Inc. Controlled release immunomodulator compositions and methods for the treatment of otic disorders
US8846770B2 (en) * 2008-06-18 2014-09-30 Otonomy, Inc. Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
US8349353B2 (en) 2008-06-27 2013-01-08 Otonomy, Inc. Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders
WO2010011466A2 (en) 2008-06-27 2010-01-28 Otonomy, Inc. Controlled-release cns modulating compositions and methods for the treatment of otic disorders
US8318817B2 (en) 2008-07-21 2012-11-27 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8496957B2 (en) 2008-07-21 2013-07-30 Otonomy, Inc Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
AU2014200457B2 (en) * 2008-07-21 2016-07-28 Otonomy, Inc. Controlled release antimicrobial compositions and methods for the treatment of otic disorders
US8784870B2 (en) 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
JP5421366B2 (ja) 2008-07-21 2014-02-19 オトノミ―，インク． 制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
US8399018B2 (en) 2008-07-21 2013-03-19 Otonomy, Inc. Controlled release ion channel modulator compositions and methods for the treatment of otic disorders
WO2010048095A2 (en) * 2008-10-22 2010-04-29 House Ear Institute Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor
US20100104654A1 (en) 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
US8920855B1 (en) 2012-10-30 2014-12-30 Setem Hemth, Inc Methods of topically treating tinnitus and related disorders
MX2016002408A (es) 2013-08-27 2016-10-28 Otonomy Inc Metodos para el tratamiento de trastornos oticos pediatricos.
KR20190024983A (ko) 2016-06-29 2019-03-08 오토노미, 인코포레이티드 트리글리세라이드 귀 제제 및 이의 용도
US11040004B2 (en) 2016-09-16 2021-06-22 Otonomy, Inc. Otic gel formulations for treating otitis externa

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
US5176654B1 (en) 1990-12-07 1999-12-07 Simeon B Schreiber Method and apparatus for otologic administration of medicament
KR950000664A (ko) * 1993-06-14 1995-01-03 우에노 도시오 신규한 13,14-디히드로-피지에프 2 베타(PGF2β) 및 이의 이소프로필 에스테르
US5510383A (en) * 1993-08-03 1996-04-23 Alcon Laboratories, Inc. Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5421818A (en) * 1993-10-18 1995-06-06 Inner Ear Medical Delivery Systems, Inc. Multi-functional inner ear treatment and diagnostic system
KR950032113A (ko) * 1994-03-22 1995-12-20 우에노 도시오 프로스타글란딘 에프 에스테르
US6045528A (en) * 1997-06-13 2000-04-04 Intraear, Inc. Inner ear fluid transfer and diagnostic system
CA2314369A1 (en) * 1997-12-18 1999-06-24 Nathan Earl Scott Prostaglandin e2/f2.alpha. combination for treating impotence and enhancing sexual arousal
US6335459B1 (en) * 1998-12-23 2002-01-01 Syntex (U.S.A.) Llc Aryl carboxylic acid and aryl tetrazole derivatives as IP receptor modulators
US6120484A (en) * 1999-02-17 2000-09-19 Silverstein; Herbert Otological implant for delivery of medicament and method of using same

Also Published As

Publication number Publication date
JP4960931B2 (ja) 2012-06-27
US7498360B2 (en) 2009-03-03
MXPA03006439A (es) 2003-09-22
BR0206568A (pt) 2004-01-27
DE60236639D1 (de) 2010-07-22
ATE470446T1 (de) 2010-06-15
JP4202135B2 (ja) 2008-12-24
US20040029970A1 (en) 2004-02-12
CN1307998C (zh) 2007-04-04
HK1061975A1 (en) 2004-10-15
NZ526972A (en) 2005-02-25
JP2009019043A (ja) 2009-01-29
EP1351693B1 (en) 2010-06-09
AU2002219765B2 (en) 2005-10-27
CA2434272C (en) 2011-03-08
CA2434272A1 (en) 2002-07-25
EP1351693A1 (en) 2003-10-15
WO2002056890A1 (en) 2002-07-25
JP2004520361A (ja) 2004-07-08
PL362803A1 (en) 2004-11-02
CN1487832A (zh) 2004-04-07

Similar Documents

Publication Publication Date Title
SE0100158D0 (sv) Novel method and composition for local treatment of Meniere´s disease and tinnitus
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
HN1999000045A (es) Derivados biciclicos del acido hidroxamico
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
PT1079806E (pt) Preparacoes para a aplicacao de anti-inflamatorios, especialmente, agentes anti-septicos e/ou agentes de promocao da cura de feridas, no tracto respiratorio superior e/ou no ouvido
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
PA8588601A1 (es) Administracion combinada de una indolinona junto a un agente quimioterapeutico para el tratamiento de enfermedades de proliferacion celular
YU71901A (sh) NOVE VRSTE LEKOVITIH KOMPOZICIJA NA BAZI JEDINJENJA KOJA DELUJU ANTIHOLINERGIJSKI I beta-MIMETIKA
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
EA200700777A1 (ru) Содержащие октенидин таблетки для рассасывания, предназначенные для лечения воспалительных заболеваний полости рта и глотки
SE9900961D0 (sv) Novel compounds
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
DK0998287T3 (da) Anvendelse af levobupivacain
DE60128100D1 (de) Analgetisches arzneimittel
BR0203517A (pt) Composição farmacêutica estéril aquosa, e, método para preparar uma composição farmacêutica estéril aquosa
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
SE9802209D0 (sv) Novel compounds
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
HRPK20040328B3 (en) Pharmaceutical composition comprising gamma-butyrobetaine
UA40495A (uk) Склад для лікування захворювань ясен
EA200501282A1 (ru) Применение эсциталопрама для лечения расстройства, связанного с посттравматическим стрессом
EA200100801A1 (ru) Применение половых гормонов при изготовлении фармацевтической композиции для назального введения, предназначенной для лечения нежелательного маточного кровотечения